NeoStem expands IP coverage of cardiovascular asset AMR-001 | The complete text of Drugs (Prices Control) Order, 2013 | Please Note Our New Telephone Number + 91 22 22063132, 22063135, 22063138, TeleFax: 22063133 .
       
  Editorial
 INDECISION ON ANALGIN   
 Wednesday, May 15, 2013 
 Once again a demand for banning analgin, one of the oldest analgesics marketed and widely used in the country, has come to the fore. 
  Past Editorial...  
TODAY'S NEWS
18:00  [IST]NeoStem expands IP coverage of cardiovascular asset AMR-001
17:20  [IST]India, UK ink MoU on cooperation in healthcare sector
17:00  [IST]Valtech reports two patients with MR treated with percutaneous Annuloplastiegerät without open-heart surgery
16:15  [IST]Apollo Hospital net jumps by 27.3% in Q4, dividend at 110%
16:00  [IST]Transgenomic introduces CRC RAScan mutation detection test for use in patients with metastatic colorectal cancer
15:00  [IST]PuraMed introduces business-to-business migraine first aid kit to promote workplace health and wellness
more news >>
TOP NEWS
08:00  [IST]NPPA to start announcing revised prices of essential drugs as per new DPCO soon
08:00  [IST]New DPCO puts in place safeguards against discontinuation of essential drugs production
08:00  [IST]New DPCO may hit the prospects of MNCs, may force withdraw some products from market
08:00  [IST]AIDS Control Dept wants Planning Commission to revise sanctioned allocation for current Plan period
08:00  [IST]US FDA issues draft guideline on expanded access to IND for treatment; expects industry views before July 1
08:00  [IST]KPMA wants state govt to declare pharma manufacturing a thrust sector
more news >>
YESTERDAY'S NEWS
16:00  [IST]Sanofi's pivotal phase III JAKARTA study for JAK2 inhibitor in myelofibrosis meets primary endpoint
15:00  [IST]AbbVie, Galapagos extend GLPG0634 clinical development pact to include Crohn's disease
14:00  [IST]St. Jude Medical's ILUMIEN OPTIS PCI Optimization System receives CE Mark approval
13:00  [IST]A*STAR, Cytos Biotech begin phase I trial with H1N1 influenza vaccine candidate
12:00  [IST]MultiCell seeks US patent for targeted delivery of noncoding Micro RNAs to treat liver cancer
11:00  [IST]Mylan launches generic Tricor tablets
more news >>
INTERVIEW  
Industry dynamics such as patent cliff will impact companies differently: Rajiv Malik
rajiv_malik.jpgRajiv Malik, president, Mylan Inc.
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Will the industry support the health ministry's directive to state licensing authorities to grant manufacturing licences in generic names only?
  
 
 
 

   
 
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
US FDA: REFUSAL
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
 
 
 
 
 
Copyright © 2010 Saffron Media Pvt. Ltd |